531 related articles for article (PubMed ID: 20018390)
1. Current status and challenges of antiretroviral research and therapy.
Esté JA; Cihlar T
Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Clinical management of HIV-1 resistance.
Paredes R; Clotet B
Antiviral Res; 2010 Jan; 85(1):245-65. PubMed ID: 19808056
[TBL] [Abstract][Full Text] [Related]
5. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
6. Update on antiretroviral therapy in paediatrics.
Penazzato M; Donà D; Wool PS; Rampon O; Giaquinto C
Antiviral Res; 2010 Jan; 85(1):266-75. PubMed ID: 19879898
[TBL] [Abstract][Full Text] [Related]
7. The evolution of HIV treatment guidelines: current state-of-the-art of ART.
Zolopa AR
Antiviral Res; 2010 Jan; 85(1):241-4. PubMed ID: 19883695
[TBL] [Abstract][Full Text] [Related]
8. Running a tightrope: regulatory challenges in the development of antiretrovirals.
Naeger LK; Struble KA; Murray JS; Birnkrant DB
Antiviral Res; 2010 Jan; 85(1):232-40. PubMed ID: 19665489
[TBL] [Abstract][Full Text] [Related]
9. Understanding and managing the adverse effects of antiretroviral therapy.
Hawkins T
Antiviral Res; 2010 Jan; 85(1):201-9. PubMed ID: 19857521
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and drug-drug interactions of antiretrovirals: an update.
Dickinson L; Khoo S; Back D
Antiviral Res; 2010 Jan; 85(1):176-89. PubMed ID: 19665485
[TBL] [Abstract][Full Text] [Related]
11. [Antiretroviral treatment for HIV infection. Where we are and where we are going?].
Sierra-Madero JG; Franco-San-Sebastián D
Rev Invest Clin; 2004; 56(2):222-31. PubMed ID: 15377075
[TBL] [Abstract][Full Text] [Related]
12. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
13. Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance.
Wensing AM; van Maarseveen NM; Nijhuis M
Antiviral Res; 2010 Jan; 85(1):59-74. PubMed ID: 19853627
[TBL] [Abstract][Full Text] [Related]
14. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
Neuman MG; Monteiro M; Rehm J
Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
[TBL] [Abstract][Full Text] [Related]
15. The future of antiretroviral therapy: challenges and needs.
Moreno S; López Aldeguer J; Arribas JR; Domingo P; Iribarren JA; Ribera E; Rivero A; Pulido F;
J Antimicrob Chemother; 2010 May; 65(5):827-35. PubMed ID: 20228080
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
17. Drug-resistant human immunodefiency virus.
Kozal MJ
Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of treatment failure: a focus on recent trends.
Hull MW; Lima VD; Hogg RS; Harrigan PR; Montaner JS
Curr Opin HIV AIDS; 2009 Nov; 4(6):467-73. PubMed ID: 20048712
[TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
Kwara A; Flanigan TP; Carter EJ
Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
[TBL] [Abstract][Full Text] [Related]
20. Treatment interruption in HIV therapy: a SMART strategy?
Jülg B; Goebel FD
Infection; 2006 Jun; 34(3):186-8. PubMed ID: 16804667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
